(Q33695532)

English

The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

multicenter clinical trial

0 references

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

Helicobacter pylori

object named as

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Peter Malfertheiner

6

object named as

Peter Malfertheiner

1 reference

Europe PubMed Central

28 July 2017

author name string

Werner Schwizer

1

1 reference

Europe PubMed Central

28 July 2017

Dieter Menne

2

1 reference

Europe PubMed Central

28 July 2017

Kurt Schütze

3

1 reference

Europe PubMed Central

28 July 2017

Michael Vieth

4

1 reference

Europe PubMed Central

28 July 2017

Reiner Goergens

5

1 reference

Europe PubMed Central

28 July 2017

Andreas Leodolter

7

1 reference

Europe PubMed Central

28 July 2017

Michael Fried

8

1 reference

Europe PubMed Central

28 July 2017

Mark R Fox

9

1 reference

Europe PubMed Central

28 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2013

1 reference

Europe PubMed Central

28 July 2017

United European gastroenterology journal

1 reference

Europe PubMed Central

28 July 2017

1

1 reference

Europe PubMed Central

28 July 2017

4

1 reference

Europe PubMed Central

28 July 2017

226-235

1 reference

Europe PubMed Central

28 July 2017

Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Gastro-oesophageal reflux disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

21 June 2018

Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Psychosocial factors are more important than disease activity in determining gastrointestinal symptoms and health status in adults at a celiac disease referral center.

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

30 October 2018

The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040789

30 October 2018

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1177%2F2050640613484020

21 January 2018

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Narcotic bowel syndrome treated with clonidine. Resolution of abdominal pain and intestinal pseudo-obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24917966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/2050640613484020

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33695532&oldid=1801220106"